Persistent URL of this record https://hdl.handle.net/1887/106466
In Collections
This item can be found in the following collections:
Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study
- All authors
- Heijde, D. van der; Tanaka, Y.; Fleischmann, R.M.; Keystone, E.; Kremer, J.M.; Zerbini, C.; Cardiel, M.H.; Cohen, S.B.; Nash, P.T.; Song, Y.; Tegzova, D.; Wyman, B.; Gruben, D.; Benda, B.; Wallenstein, G.; Krishnaswami, S.; Zwillich, S.H.; Bradley, J.; Connell, C.A.; ORAL Scan Investigators
- Date
- 2012-10-31
- Journal
- Arthritis and Rheumatism
- Volume
- 64
- Issue
- 10
- Pages
- S546 - S547